ZAMBA: Zoledronic Acid for Modic Back Pain. A randomized, double blind, placebo-controlled, multicenter trial
The ZAMBA study is currently investigating a medicine called zoledronic acid for people who suffer from long-lasting back pain. This research is a 'Phase III' clinical trial, which means it's one of the final steps to see if a new treatment works and is safe. The study is designed to compare zoledronic acid with a 'dummy' treatment (placebo) to understand if it can reduce back pain and improve how well people can do everyday tasks. Researchers will look at changes in participants' ability to perform daily activities and their pain levels over a period of one year. This information will help doctors understand if this medicine could be a new way to help manage back pain.
At a glance
What is this study about?
This study, called ZAMBA (Zoledronic Acid for Modic Back Pain), is a research project looking into a medicine called zoledronic acid to see if it can help people who have ongoing lower back pain. Many people suffer from back pain, and finding new ways to treat it is very important. This study is trying to understand if zoledronic acid can make a difference in how much pain people feel and how much their back pain affects their daily lives.
To make sure the results are fair and reliable, this study is set up as a 'randomized, double-blind, placebo-controlled trial'. This means that some people will receive the actual medicine (zoledronic acid), while others will receive a 'dummy' treatment called a placebo. Neither the patients nor their doctors will know who is getting which treatment. This helps ensure that any changes observed are due to the medicine itself and not other factors, like knowing you're getting a new treatment.
The main goal of the study is to see how much people's ability to do daily activities improves over one year after starting treatment. Researchers will use a special questionnaire called the Oswestry Disability Index (ODI) to measure this. They will also look at how pain intensity changes, as well as general quality of life and what other treatments people might be using. This thorough approach helps build a complete picture of whether zoledronic acid is a helpful treatment for back pain.
Key takeaways
- The ZAMBA study is investigating zoledronic acid for ongoing low back pain.
- It's a comparison study where some get active medicine, some get a 'dummy' treatment.
- The main goal is to see if it improves daily activities over one year.
- You would be monitored closely for a year if you participate.
- Both men and women, aged 18 and older, with low back pain, may be eligible.
Who may be eligible?
To join the ZAMBA study, you would need to be an adult, at least 18 years old, and can be any age above that. Both men and women are welcome to take part.
The study is specifically looking for people who experience ongoing low back pain. There will be other specific rules about your health and medical history that the study doctors will check to make sure the study is a safe and suitable option for you.
It's important to discuss your full medical history with the study team to see if you meet all the criteria.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years of age or older?
- Do you experience ongoing low back pain?
- Are you comfortable with receiving an intravenous (IV) drip as part of the treatment?
- Are you able to attend follow-up appointments over a one-year period?
What does participation involve?
If you decide to take part in the ZAMBA study, you would be involved for a total of one year. During this time, you would receive either a single dose of the study medicine (zoledronic acid) or a non-active solution (placebo), both given through a drip into your arm. You wouldn't know which one you were getting.
Your involvement would include a few visits to the study clinic. At these visits, doctors and nurses would perform various assessments to track your progress. These assessments would involve answering questionnaires about your pain levels and how your back pain affects your daily activities. You might also be asked about any other medicines or treatments you are using for your back.
After receiving the treatment, you would have follow-up appointments over the course of the year. These appointments are important for the study team to monitor how you are feeling, check for any changes in your back pain, and ensure your safety throughout the study.
Potential risks and benefits
Locations (1)
- —UnverifiedNorway
Common questions
What is zoledronic acid?
Zoledronic acid is a medicine that is already used for certain bone conditions, but this study is looking at whether it can also help with back pain.
What is a placebo?
A placebo is a 'dummy' treatment that looks just like the real medicine but contains no active drug. It helps researchers see if the actual medicine works better than no treatment.
Will I know if I'm getting the real medicine?
No, neither you nor your doctor will know if you're receiving the active medicine or the placebo. This is called 'double-blind' and helps ensure fair results.
How long does the study last?
If you join, your participation in the study will last for one year.
Why is this study important?
This study aims to discover if zoledronic acid could be a new and effective treatment option for people suffering from ongoing low back pain.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.